Jianting Wen

571 total citations
43 papers, 420 citations indexed

About

Jianting Wen is a scholar working on Rheumatology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jianting Wen has authored 43 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Rheumatology, 21 papers in Molecular Biology and 18 papers in Cancer Research. Recurrent topics in Jianting Wen's work include Rheumatoid Arthritis Research and Therapies (19 papers), Cancer-related molecular mechanisms research (17 papers) and Circular RNAs in diseases (8 papers). Jianting Wen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (19 papers), Cancer-related molecular mechanisms research (17 papers) and Circular RNAs in diseases (8 papers). Jianting Wen collaborates with scholars based in China and Hong Kong. Jianting Wen's co-authors include Jian Liu, Ling Xin, Yanqiu Sun, Lei Wan, Jie Wang, Yanyan Fang, Dan Huang, Xin Wang, Fanfan Wang and Hui Jiang and has published in prestigious journals such as Frontiers in Immunology, Journal of Ethnopharmacology and BioMed Research International.

In The Last Decade

Jianting Wen

37 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianting Wen China 11 246 200 173 53 52 43 420
Fanru Meng China 7 195 0.8× 171 0.9× 98 0.6× 60 1.1× 27 0.5× 8 364
Zhongbin Xia China 7 140 0.6× 140 0.7× 84 0.5× 54 1.0× 20 0.4× 14 292
Yehua Jin China 10 135 0.5× 72 0.4× 125 0.7× 48 0.9× 15 0.3× 15 309
Huimin Ding China 10 178 0.7× 66 0.3× 55 0.3× 46 0.9× 20 0.4× 18 282
Beatrice Schmid Austria 2 193 0.8× 100 0.5× 177 1.0× 72 1.4× 23 0.4× 8 373
Hanzhi Ling China 8 194 0.8× 90 0.5× 61 0.4× 92 1.7× 13 0.3× 9 333
Yoshihiro Tanimori Japan 9 184 0.7× 136 0.7× 16 0.1× 35 0.7× 10 0.2× 9 379

Countries citing papers authored by Jianting Wen

Since Specialization
Citations

This map shows the geographic impact of Jianting Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianting Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianting Wen more than expected).

Fields of papers citing papers by Jianting Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianting Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianting Wen. The network helps show where Jianting Wen may publish in the future.

Co-authorship network of co-authors of Jianting Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Jianting Wen. A scholar is included among the top collaborators of Jianting Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianting Wen. Jianting Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Xinyue, Hui Li, Xiao Hua Wang, et al.. (2025). Clematichinenoside AR alleviates rheumatoid arthritis by inhibiting synovial angiogenesis through the HIF-1α/VEGFA/ANG2 axis. Phytomedicine. 139. 156552–156552. 6 indexed citations
2.
5.
Wen, Jianting, Jian Liu, Lei Wan, & Fanfan Wang. (2025). Novel insights into the crosstalk between non-coding RNA and apoptosis in rheumatoid arthritis: diagnostic functions and therapeutic applications. Frontiers in Immunology. 16. 1550839–1550839.
11.
Wang, Fanfan, et al.. (2023). Hypercoagulability in Rheumatoid Arthritis: A Bibliometric Analysis and Retrospective Data Mining Study. ACS Omega. 8(50). 48522–48534. 6 indexed citations
12.
13.
Sun, Yanqiu, et al.. (2022). Xinfeng capsule inhibits inflammation and oxidative stress in rheumatoid arthritis by up-regulating LINC00638 and activating Nrf2/HO-1 pathway. Journal of Ethnopharmacology. 301. 115839–115839. 40 indexed citations
14.
Wen, Jianting, Jian Liu, Lei Wan, et al.. (2022). Triptolide inhibits cell growth and inflammatory response of fibroblast-like synoviocytes by modulating hsa-circ-0003353/microRNA-31-5p/CDK1 axis in rheumatoid arthritis. International Immunopharmacology. 106. 108616–108616. 32 indexed citations
16.
Fang, Yanyan, et al.. (2022). Knockdown of circular RNA hsa_circ_0003307 inhibits synovial inflammation in ankylosing spondylitis by regulating the PI3K/AKT pathway. Advances in Clinical and Experimental Medicine. 31(7). 781–788. 4 indexed citations
17.
Wen, Jianting, Jian Liu, Ling Xin, et al.. (2021). Effective factors on Sharp Score in patients with rheumatoid arthritis: a retrospective study. BMC Musculoskeletal Disorders. 22(1). 865–865. 4 indexed citations
18.
Wen, Jianting, Jian Liu, Xin Wang, & Jie Wang. (2021). Expression and clinical significance of circular RNAs related to immunity and inflammation in patients with rheumatoid arthritis. International Immunopharmacology. 92. 107366–107366. 26 indexed citations
19.
Fang, Yanyan, Jian Liu, Ling Xin, et al.. (2020). Identifying Compound Effect of Drugs on Rheumatoid Arthritis Treatment Based on the Association Rule and a Random Walking‐Based Model. BioMed Research International. 2020(1). 4031015–4031015. 24 indexed citations
20.
Wen, Jianting, Jian Liu, Bing Wang, et al.. (2020). Prediction of Self-Perception of Patient in Rheumatoid Arthritis With the Key RNAs Expression Profiles. Frontiers in Medicine. 7. 567–567. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026